Literature DB >> 10746633

Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.

B Draznin1, P Miles, Y Kruszynska, J Olefsky, J Friedman, I Golovchenko, R Stjernholm, K Wall, M Reitman, D Accili, R Cooksey, D McClain, M Goalstone.   

Abstract

To investigate the cause and effect relationship between hyperinsulinemia and the increased amounts of farnesylated p21Ras, we performed hyperinsulinemic euglycemic clamps in normal weight volunteers as well as in normal mice and dogs. Insulin infusions significantly raised the amounts of farnesylated p21Ras in the white blood cells of humans, in liver samples of mice and dogs, and in aorta samples of mice. Obese hyperinsulinemic individuals and dogs (made hyperinsulinemic by surgical diversion of the pancreatic outflow from the portal vein into the vena cava) displayed increased amounts of farnesylated p21Ras before the hyperinsulinemic clamps. Infusions of insulin did not alter the already increased levels of farnesylated p21Ras in these experimental models. To further investigate the role of acquired insulin resistance in modulating insulin's effect on p21Ras prenylation, we induced insulin resistance in rats by glucosamine infusion. Insulin-resistant glucosamine-treated animals displayed significantly increased farnesylated p21Ras in response to insulin infusion compared to that in control saline-treated animals. Transgenic models of insulin resistance (heterozygous insulin receptor substrate-1 knockout mice, A-ZIP/F-1 fatless mice, and animals overexpressing glutamine:fructose-6-phosphate amidotransferase) contained increased amounts of farnesylated p21Ras. We conclude that hyperinsulinemia, either endogenous (a prominent feature of insulin resistance) or produced by infusions of insulin, increases the amounts of farnesylated p21Ras in humans, mice, and dogs. This aspect of insulin action may represent one facet of the molecular mechanism of the potentially detrimental influence of hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746633     DOI: 10.1210/endo.141.4.7411

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Mitogenic action of insulin: friend, foe or 'frenemy'?

Authors:  B Draznin
Journal:  Diabetologia       Date:  2009-10-23       Impact factor: 10.122

2.  Prenylation differentially inhibits insulin-dependent immediate early gene mRNA expression.

Authors:  J Lee Franklin; Maggie O Amsler; Joseph L Messina
Journal:  Biochem Biophys Res Commun       Date:  2016-04-14       Impact factor: 3.575

Review 3.  How does blood glucose control with insulin save lives in intensive care?

Authors:  Greet Van den Berghe
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Ras in cancer and developmental diseases.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

5.  Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy.

Authors:  Mamta Kanwar; Renu A Kowluru
Journal:  Microvasc Res       Date:  2008-04-25       Impact factor: 3.514

6.  Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels.

Authors:  Katarzyna A Cieslik; JoAnn Trial; Signe Carlson; George E Taffet; Mark L Entman
Journal:  FASEB J       Date:  2013-01-09       Impact factor: 5.191

Review 7.  HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  Statins in the treatment of polycystic ovary syndrome.

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Semin Reprod Med       Date:  2008-01       Impact factor: 1.303

Review 9.  Insulin resistance, metabolic stress, and atherosclerosis.

Authors:  Meghana Pansuria; Hang Xi; Le Li; Xiao-Feng Yang; Hong Wang
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

Review 10.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.